Jeffrey Barth Weilburg, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diagnostic Imaging | 11 | 2021 | 3508 | 0.970 |
Why?
|
| Antidepressive Agents | 8 | 2015 | 2839 | 0.690 |
Why?
|
| Outpatients | 4 | 2019 | 1486 | 0.470 |
Why?
|
| Managed Care Programs | 2 | 2018 | 950 | 0.460 |
Why?
|
| Emergency Service, Hospital | 6 | 2022 | 7659 | 0.440 |
Why?
|
| Panic Disorder | 4 | 2000 | 616 | 0.430 |
Why?
|
| Utilization Review | 1 | 2013 | 392 | 0.400 |
Why?
|
| Electronic Health Records | 8 | 2019 | 4463 | 0.360 |
Why?
|
| Prescription Drugs | 1 | 2015 | 595 | 0.310 |
Why?
|
| Primary Health Care | 4 | 2017 | 4556 | 0.280 |
Why?
|
| Medicaid | 1 | 2018 | 2736 | 0.260 |
Why?
|
| Physicians, Family | 1 | 2007 | 345 | 0.260 |
Why?
|
| Medical Order Entry Systems | 4 | 2014 | 544 | 0.250 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 3023 | 0.250 |
Why?
|
| Physicians, Primary Care | 2 | 2022 | 591 | 0.230 |
Why?
|
| Specialization | 2 | 2018 | 777 | 0.220 |
Why?
|
| Unnecessary Procedures | 2 | 2017 | 431 | 0.210 |
Why?
|
| Drug Utilization Review | 1 | 2003 | 245 | 0.210 |
Why?
|
| Norepinephrine | 1 | 2004 | 909 | 0.200 |
Why?
|
| Decision Support Systems, Clinical | 4 | 2015 | 1162 | 0.200 |
Why?
|
| Mental Disorders | 4 | 2018 | 6601 | 0.190 |
Why?
|
| Depression | 4 | 2013 | 7767 | 0.190 |
Why?
|
| Medicare | 1 | 2018 | 6566 | 0.180 |
Why?
|
| Academic Medical Centers | 4 | 2019 | 2759 | 0.180 |
Why?
|
| Anxiety Disorders | 3 | 2004 | 2691 | 0.170 |
Why?
|
| Drug Costs | 2 | 2004 | 1105 | 0.170 |
Why?
|
| Panic | 3 | 1987 | 106 | 0.170 |
Why?
|
| Physician-Patient Relations | 2 | 2013 | 3227 | 0.160 |
Why?
|
| Physician Incentive Plans | 1 | 2019 | 161 | 0.150 |
Why?
|
| Professional Practice Location | 1 | 2017 | 59 | 0.150 |
Why?
|
| Ambulatory Care | 6 | 2013 | 2708 | 0.140 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2019 | 941 | 0.140 |
Why?
|
| Depressive Disorder | 5 | 1989 | 3750 | 0.130 |
Why?
|
| Epilepsy, Complex Partial | 1 | 1995 | 62 | 0.130 |
Why?
|
| Patient Care Management | 1 | 2019 | 306 | 0.130 |
Why?
|
| Somnambulism | 1 | 1995 | 13 | 0.130 |
Why?
|
| Phobic Disorders | 2 | 1988 | 439 | 0.120 |
Why?
|
| Data Display | 1 | 2015 | 182 | 0.120 |
Why?
|
| Boston | 5 | 2020 | 9311 | 0.120 |
Why?
|
| Fear | 3 | 1987 | 1439 | 0.120 |
Why?
|
| Psychiatry | 3 | 2016 | 1695 | 0.110 |
Why?
|
| Medical Informatics Applications | 1 | 2015 | 186 | 0.110 |
Why?
|
| Gastroenterology | 1 | 2019 | 536 | 0.110 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2014 | 434 | 0.110 |
Why?
|
| Airway Obstruction | 2 | 1988 | 663 | 0.100 |
Why?
|
| Humans | 59 | 2022 | 744220 | 0.100 |
Why?
|
| Epilepsies, Partial | 1 | 1995 | 436 | 0.100 |
Why?
|
| Referral and Consultation | 3 | 2009 | 3528 | 0.100 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2014 | 503 | 0.100 |
Why?
|
| Health Maintenance Organizations | 2 | 2004 | 642 | 0.100 |
Why?
|
| Alprazolam | 2 | 1988 | 98 | 0.100 |
Why?
|
| Feedback | 1 | 2014 | 795 | 0.100 |
Why?
|
| Self Report | 2 | 2022 | 3558 | 0.090 |
Why?
|
| Patient Compliance | 2 | 2015 | 2684 | 0.090 |
Why?
|
| Residence Characteristics | 1 | 2020 | 2050 | 0.090 |
Why?
|
| Adult | 31 | 2022 | 214035 | 0.090 |
Why?
|
| Middle Aged | 26 | 2020 | 213367 | 0.090 |
Why?
|
| Epilepsy | 3 | 2000 | 3310 | 0.090 |
Why?
|
| Female | 39 | 2022 | 380197 | 0.090 |
Why?
|
| Male | 35 | 2022 | 350027 | 0.090 |
Why?
|
| Health Services Research | 3 | 2015 | 1836 | 0.090 |
Why?
|
| Fluoxetine | 2 | 1989 | 749 | 0.080 |
Why?
|
| Mitral Valve | 1 | 2017 | 1490 | 0.080 |
Why?
|
| Workflow | 1 | 2013 | 847 | 0.080 |
Why?
|
| Retrospective Studies | 10 | 2020 | 77426 | 0.080 |
Why?
|
| Desipramine | 1 | 1989 | 184 | 0.080 |
Why?
|
| Electroencephalography | 6 | 1995 | 6150 | 0.080 |
Why?
|
| Triazolam | 1 | 1987 | 16 | 0.080 |
Why?
|
| Hyperphagia | 2 | 1985 | 136 | 0.080 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2017 | 1421 | 0.080 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2016 | 1007 | 0.070 |
Why?
|
| United States | 9 | 2018 | 69867 | 0.070 |
Why?
|
| Hospitals, General | 2 | 2017 | 749 | 0.070 |
Why?
|
| Epilepsy, Temporal Lobe | 2 | 1987 | 403 | 0.070 |
Why?
|
| Aged | 16 | 2020 | 163253 | 0.070 |
Why?
|
| New England | 3 | 2014 | 1022 | 0.070 |
Why?
|
| Radiography | 2 | 2013 | 7022 | 0.070 |
Why?
|
| Bipolar Disorder | 4 | 2012 | 5027 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2016 | 1643 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2208 | 0.060 |
Why?
|
| Echocardiography | 1 | 2017 | 5103 | 0.060 |
Why?
|
| Cerebellar Diseases | 1 | 2007 | 222 | 0.060 |
Why?
|
| Depressive Disorder, Major | 2 | 2012 | 4645 | 0.060 |
Why?
|
| Aged, 80 and over | 5 | 2018 | 57768 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2292 | 0.060 |
Why?
|
| Education, Medical, Graduate | 1 | 2016 | 2291 | 0.060 |
Why?
|
| Radiology | 2 | 2009 | 2099 | 0.060 |
Why?
|
| Pediatrics | 1 | 2019 | 3469 | 0.060 |
Why?
|
| Massachusetts | 6 | 2019 | 8663 | 0.060 |
Why?
|
| User-Computer Interface | 2 | 2010 | 1426 | 0.060 |
Why?
|
| Brain Diseases | 1 | 1993 | 1564 | 0.060 |
Why?
|
| Registries | 1 | 2019 | 8090 | 0.060 |
Why?
|
| Curriculum | 1 | 2016 | 3604 | 0.060 |
Why?
|
| Radiology Department, Hospital | 1 | 2007 | 412 | 0.050 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2267 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2279 | 0.050 |
Why?
|
| Polypharmacy | 1 | 2004 | 294 | 0.050 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 3158 | 0.050 |
Why?
|
| Radiology Information Systems | 1 | 2006 | 523 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2012 | 63119 | 0.050 |
Why?
|
| Clonazepam | 2 | 1993 | 136 | 0.050 |
Why?
|
| Health Care Costs | 2 | 2007 | 3209 | 0.050 |
Why?
|
| Physicians | 1 | 2018 | 4564 | 0.050 |
Why?
|
| Health Care Surveys | 1 | 2007 | 2453 | 0.040 |
Why?
|
| Cerebellum | 1 | 2007 | 1490 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2013 | 6442 | 0.040 |
Why?
|
| Anticonvulsants | 2 | 2000 | 1917 | 0.040 |
Why?
|
| Pilot Projects | 4 | 2013 | 8321 | 0.040 |
Why?
|
| Uncertainty | 1 | 2022 | 734 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5319 | 0.040 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 683 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2018 | 53280 | 0.030 |
Why?
|
| Social Responsibility | 1 | 2019 | 389 | 0.030 |
Why?
|
| Propylene Glycols | 1 | 1996 | 92 | 0.030 |
Why?
|
| Biomedical Research | 1 | 2011 | 3311 | 0.030 |
Why?
|
| Agoraphobia | 1 | 1995 | 179 | 0.030 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1996 | 96 | 0.030 |
Why?
|
| Young Adult | 4 | 2014 | 56436 | 0.030 |
Why?
|
| Psychiatric Department, Hospital | 1 | 1995 | 135 | 0.030 |
Why?
|
| Nortriptyline | 1 | 2014 | 81 | 0.030 |
Why?
|
| Current Procedural Terminology | 1 | 2015 | 92 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2014 | 110 | 0.030 |
Why?
|
| Internet | 1 | 2006 | 3063 | 0.030 |
Why?
|
| Medicare Part B | 1 | 2015 | 108 | 0.030 |
Why?
|
| Patient Care Team | 2 | 1995 | 2529 | 0.030 |
Why?
|
| Radio Frequency Identification Device | 1 | 2013 | 21 | 0.030 |
Why?
|
| Diagnosis, Differential | 3 | 1995 | 12961 | 0.030 |
Why?
|
| Risk Factors | 6 | 2020 | 72280 | 0.030 |
Why?
|
| Longitudinal Studies | 3 | 2019 | 13990 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2013 | 25618 | 0.030 |
Why?
|
| Genome-Wide Association Study | 1 | 2012 | 12264 | 0.030 |
Why?
|
| Health Care Rationing | 1 | 2016 | 437 | 0.030 |
Why?
|
| Obsessive-Compulsive Disorder | 2 | 1994 | 1444 | 0.030 |
Why?
|
| Bupropion | 1 | 2014 | 303 | 0.030 |
Why?
|
| Medicine | 2 | 2012 | 946 | 0.030 |
Why?
|
| Perceptual Disorders | 1 | 1994 | 196 | 0.030 |
Why?
|
| Monitoring, Ambulatory | 1 | 1995 | 355 | 0.030 |
Why?
|
| Carbamazepine | 1 | 1993 | 229 | 0.030 |
Why?
|
| Drug Interactions | 2 | 2012 | 1458 | 0.030 |
Why?
|
| Sleep, REM | 2 | 1985 | 595 | 0.020 |
Why?
|
| Evoked Potentials, Visual | 1 | 1994 | 427 | 0.020 |
Why?
|
| Adolescent | 3 | 2013 | 85759 | 0.020 |
Why?
|
| Citalopram | 1 | 2014 | 404 | 0.020 |
Why?
|
| Infant | 1 | 2013 | 35129 | 0.020 |
Why?
|
| Group Practice | 1 | 2012 | 149 | 0.020 |
Why?
|
| Evoked Potentials, Auditory | 1 | 1994 | 525 | 0.020 |
Why?
|
| Health Services Needs and Demand | 1 | 2019 | 1411 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 40992 | 0.020 |
Why?
|
| Comorbidity | 2 | 2006 | 10387 | 0.020 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 7784 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2012 | 17449 | 0.020 |
Why?
|
| Odds Ratio | 2 | 2017 | 9849 | 0.020 |
Why?
|
| Clomipramine | 1 | 1989 | 54 | 0.020 |
Why?
|
| Trazodone | 1 | 1989 | 66 | 0.020 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2004 | 3256 | 0.020 |
Why?
|
| Leadership | 1 | 2019 | 1357 | 0.020 |
Why?
|
| Neurologic Examination | 1 | 1993 | 931 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 1995 | 6037 | 0.020 |
Why?
|
| Motivation | 1 | 2019 | 1971 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 15538 | 0.020 |
Why?
|
| Sleep | 1 | 1985 | 4623 | 0.020 |
Why?
|
| Drug Therapy | 1 | 2012 | 497 | 0.020 |
Why?
|
| Therapeutic Equivalency | 1 | 1989 | 145 | 0.020 |
Why?
|
| Incidence | 2 | 2013 | 20945 | 0.020 |
Why?
|
| Child | 2 | 2013 | 77679 | 0.020 |
Why?
|
| Brain | 6 | 1995 | 26413 | 0.020 |
Why?
|
| Diabetes Mellitus | 1 | 2006 | 5755 | 0.020 |
Why?
|
| Monitoring, Physiologic | 1 | 1995 | 1737 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2006 | 6882 | 0.020 |
Why?
|
| Systems Integration | 1 | 2009 | 440 | 0.020 |
Why?
|
| Linear Models | 1 | 2017 | 5953 | 0.020 |
Why?
|
| Insurance, Health | 1 | 2019 | 2494 | 0.020 |
Why?
|
| Time Factors | 3 | 2017 | 40063 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 2017 | 2266 | 0.020 |
Why?
|
| Lithium | 1 | 1990 | 601 | 0.020 |
Why?
|
| Amantadine | 1 | 1986 | 55 | 0.020 |
Why?
|
| Neuroleptic Malignant Syndrome | 1 | 1986 | 71 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2011 | 867 | 0.020 |
Why?
|
| Patients | 1 | 2012 | 900 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2013 | 25043 | 0.020 |
Why?
|
| Limbic System | 1 | 1987 | 426 | 0.020 |
Why?
|
| Drug Therapy, Combination | 3 | 1990 | 6485 | 0.020 |
Why?
|
| Seizures | 2 | 1996 | 2859 | 0.010 |
Why?
|
| Hypotension, Orthostatic | 1 | 1987 | 255 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2019 | 3746 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3509 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 1986 | 390 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2019 | 35423 | 0.010 |
Why?
|
| ROC Curve | 1 | 2011 | 3527 | 0.010 |
Why?
|
| Natural Language Processing | 1 | 2011 | 1040 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10262 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 15070 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2012 | 40559 | 0.010 |
Why?
|
| Software | 1 | 2015 | 4442 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2006 | 15161 | 0.010 |
Why?
|
| Benzodiazepines | 1 | 1986 | 1101 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 7281 | 0.010 |
Why?
|
| Electromyography | 1 | 1985 | 1391 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1987 | 1670 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3591 | 0.010 |
Why?
|
| Reaction Time | 1 | 1985 | 2102 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2012 | 9147 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2012 | 7730 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 12718 | 0.010 |
Why?
|
| Phenylcarbamates | 1 | 1996 | 38 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1990 | 3058 | 0.010 |
Why?
|
| Logistic Models | 1 | 2011 | 13409 | 0.010 |
Why?
|
| Anorexia Nervosa | 1 | 1985 | 1286 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2009 | 12244 | 0.010 |
Why?
|
| Body Weight | 1 | 1986 | 4666 | 0.010 |
Why?
|
| Drug Prescriptions | 1 | 2004 | 1637 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 21752 | 0.010 |
Why?
|
| Valproic Acid | 1 | 1996 | 445 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2012 | 15525 | 0.010 |
Why?
|
| Attitude of Health Personnel | 1 | 2006 | 3842 | 0.010 |
Why?
|
| Cognition Disorders | 1 | 2007 | 4041 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 39045 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 2006 | 4371 | 0.010 |
Why?
|
| Algorithms | 1 | 2011 | 13885 | 0.010 |
Why?
|
| Personality Tests | 1 | 1989 | 83 | 0.010 |
Why?
|
| Acoustic Stimulation | 1 | 1994 | 1217 | 0.010 |
Why?
|
| Research Design | 1 | 1985 | 5987 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1994 | 1770 | 0.010 |
Why?
|
| Age Factors | 1 | 2004 | 18367 | 0.000 |
Why?
|
| Imipramine | 1 | 1987 | 97 | 0.000 |
Why?
|
| Pulse | 1 | 1987 | 229 | 0.000 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1987 | 158 | 0.000 |
Why?
|
| Research | 1 | 1995 | 1999 | 0.000 |
Why?
|
| Bromocriptine | 1 | 1986 | 111 | 0.000 |
Why?
|
| Recurrence | 2 | 1989 | 8343 | 0.000 |
Why?
|
| Electrophysiology | 1 | 1989 | 1310 | 0.000 |
Why?
|
| Forecasting | 1 | 1995 | 2949 | 0.000 |
Why?
|
| Double-Blind Method | 2 | 1989 | 12035 | 0.000 |
Why?
|
| Placebos | 1 | 1989 | 1677 | 0.000 |
Why?
|
| Evoked Potentials | 1 | 1989 | 1057 | 0.000 |
Why?
|
| Combined Modality Therapy | 1 | 1995 | 8628 | 0.000 |
Why?
|
| Internship and Residency | 1 | 1995 | 5787 | 0.000 |
Why?
|
| Dementia | 1 | 1988 | 2518 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 1989 | 7908 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1989 | 6671 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 1989 | 9960 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1987 | 8551 | 0.000 |
Why?
|
| Tomography, X-Ray Computed | 1 | 1988 | 20123 | 0.000 |
Why?
|